InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

CRISPR Therapeutics AG

CRSP Clue Score37
Switzerland Fiscal year ends December CIK 0001674416 Results filed 2 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

16
Insider
Date
Role
Action
Shares
Price
Amount
Samarth Kulkarni
19 Oct 2026
Chief Executive Officer
Sell
47,837
$49.78
$2.38M
Samarth Kulkarni
14 Oct 2026
Chief Executive Officer
Sell
4,098
$49.26
$201.87K
James R. Kasinger
14 Oct 2026
General Counsel and Secretary
Sell
1,040
$49.26
$51.23K
Naimish Patel
29 May 2026
Chief Medical Officer
Sell
3,786
$55.62
$210.58K
Raju Prasad
23 Mar 2026
Chief Financial Officer
Sell
3,708
$46.78
$173.46K
Samarth Kulkarni
23 Mar 2026
Chief Executive Officer
Sell
10,020
$46.78
$468.74K
James R. Kasinger
23 Mar 2026
General Counsel and Secretary
Sell
3,182
$46.78
$148.85K
Samarth Kulkarni
16 Mar 2026
Chief Executive Officer
Sell
10,349
$48.26
$499.44K
James R. Kasinger
16 Mar 2026
General Counsel and Secretary
Sell
3,450
$48.26
$166.50K
Raju Prasad
16 Mar 2026
Chief Financial Officer
Sell
4,021
$48.26
$194.05K
Raju Prasad
16 Mar 2026
Chief Financial Officer
Sell
5,848
$48.26
$282.22K
Naimish Patel
16 Mar 2026
Chief Medical Officer
Sell
3,150
$48.26
$152.02K
Samarth Kulkarni
11 Mar 2026
Chief Executive Officer
Sell
9,798
$52.80
$517.33K
James R. Kasinger
11 Mar 2026
General Counsel and Secretary
Sell
2,800
$52.80
$147.84K
James R. Kasinger
19 Feb 2026
General Counsel and Secretary
Sell
2,112
$52.58
$111.05K
Samarth Kulkarni
19 Feb 2026
Chief Executive Officer
Sell
6,967
$52.58
$366.32K
Show all 30 transactions →

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 8
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 415,520
History held since 20 Oct 2016